Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by <i>NTRK</i> gene fusions“

Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by <i>NTRK</i> gene fusions“

The Advisory Board was held on December 24, 2021. The molecular genetic research lead specialists and national lead oncologists discussed issues of diagnosis of NTRK gene translocations in patients with non-small cell lung cancer (NSCLC), as well as current opportunities for the treatment of patient...

Full description

Bibliographic Details
Main Authors: E. V. Artamonova, V. V. Breder, L. Yu. Vladimirova, I. A. Demidova, E. N. Imyanitov, К. К. Laktionov, M. P. Matrosova, S. V. Orlov, E. О. Rodionov, D. D. Sakaeva, M. I. Sekacheva, A. V. Smolin, N. V. Fadeeva, M. L. Filipenko
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-06-01
Series:Медицинский совет
Subjects:
<i>ntrk</i> gene fusions
larotrectinib
ngs (next generation sequencing)
trk inhibitors
non-small cell lung cancer
Online Access:https://www.med-sovet.pro/jour/article/view/6916

Internet

https://www.med-sovet.pro/jour/article/view/6916

Similar Items